524804:BOM
Aurobindo Pharma Ltd
₹1,825.00
arrow_downward
-0.98%(-18.00) 1D
Nov 11, 3:59:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524804...
Open
₹1,855.00
High
₹1,856.70
Low
₹1,807.85
Mkt. cap
1.06T
Avg. vol.
71.86K
Volume
45.53K
Dividend
0.38%
Quarterly dividend
₹1.75
Ex-dividend date
Aug 8, 2025
P/E ratio
27.66
52-wk high
₹1,856.70
52-wk low
₹1,106.25
EPS
₹65.98
Shares outstanding
585.90M
No. of employees
29K
Open
₹1,855.00
High
₹1,856.70
Low
₹1,807.85
Mkt. cap
1.06T
Avg. vol.
71.86K
Volume
45.53K
Dividend
0.38%
Quarterly dividend
₹1.75
Ex-dividend date
Aug 8, 2025
P/E ratio
27.66
52-wk high
₹1,856.70
52-wk low
₹1,106.25
EPS
₹65.98
Shares outstanding
585.90M
No. of employees
29K
News stories
From web sources and news partners
TradingView
·
3 hours ago
News by CNBC TV18 on TradingView, 2026-11-11 — cnbctv:167fbd012094b:0
Yahoo Finance
·
2 days ago
Aurobindo Pharma Ltd (BOM:524804) (Q2 2027) Earnings Call Highlights: Record Revenue of ...
The Economic Times
·
1 month ago
Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29.2K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorHealth Care
IndustryPharmaceutical industry
Websiteaurobindo.com